Terms: = Breast cancer AND ACVR1, SKR1, 90, ENSG00000115170, Q04771, ACVRLK2, FOP, ALK2, ACTRI AND Treatment
5554 results:
1. A Comparative Analysis of Implant-sparing Plan
Onal C; Bozca R; Dolek Y; Elmali A; Guler OC
In Vivo; 2024; 38(3):1412-1420. PubMed ID: 38688603
[TBL] [Abstract] [Full Text] [Related]
2. True Donor Cell Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Considerations-Brief Report.
Hoffmann M; Banz Y; Halter J; Schoumans J; Tchinda J; Bacher U; Pabst T
Curr Oncol; 2024 Apr; 31(4):2067-2075. PubMed ID: 38668056
[TBL] [Abstract] [Full Text] [Related]
3. A randomized clinical trial: Efficacy of group-based acceptance and commitment therapy program for breast cancer patients with high fear of progression.
Hassani Alimolk F; McDonald FEJ; Asghari-Jafarabadi M; Ahmadi F; Zenoozian S; Lashkari M; Patterson P
Psychooncology; 2024 Apr; 33(4):e6339. PubMed ID: 38653573
[TBL] [Abstract] [Full Text] [Related]
4. NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer.
Jacobs SA; Wang Y; Abraham J; Feng H; Montero AJ; Lipchik C; Finnigan M; Jankowitz RC; Salkeni MA; Maley SK; Puhalla SL; Piette F; Quinn K; Chang K; Nagy RJ; Allegra CJ; Vehec K; Wolmark N; Lucas PC; Srinivasan A; Pogue-Geile KL
Breast Cancer Res; 2024 Apr; 26(1):69. PubMed ID: 38650031
[TBL] [Abstract] [Full Text] [Related]
5. B7-H3 Expression in breast cancer and Brain Metastasis.
Joshi V; Beecher K; Lim M; Stacey A; Feng Y; Jat PS; Duijf PHG; Simpson PT; Lakhani SR; McCart Reed AE
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612786
[TBL] [Abstract] [Full Text] [Related]
6. Active substance and mechanisms of Actinidia chinensis Planch for the treatment of breast cancer was explored based on network pharmacology and in silico study.
Xu Y; Yang J; Han X; Gan C; Wei X
Medicine (Baltimore); 2024 Apr; 103(15):e37829. PubMed ID: 38608062
[TBL] [Abstract] [Full Text] [Related]
7. Impact of chrono-radiotherapy on the prognosis and treatment-related toxicity in patients with locally advanced nasopharyngeal carcinoma: A multicenter propensity-matched study.
Lin J; Lin X; Zheng R; Lin K; Khan M; Huang X; Tian Y; Wang B; Xu B; Yuan Y; Huang Z
Chronobiol Int; 2024 Apr; 41(4):587-597. PubMed ID: 38606920
[TBL] [Abstract] [Full Text] [Related]
8. Phase II Study of Erdafitinib in Patients With Tumors With
Gong J; Mita AC; Wei Z; Cheng HH; Mitchell EP; Wright JJ; Ivy SP; Wang V; Gray RC; McShane LM; Rubinstein LV; Patton DR; Williams PM; Hamilton SR; Alva AS; Tricoli JV; Conley BA; Arteaga CL; Harris LN; O'Dwyer PJ; Chen AP; Flaherty KT
JCO Precis Oncol; 2024 Apr; 8():e2300406. PubMed ID: 38603651
[TBL] [Abstract] [Full Text] [Related]
9. Comparison of neoadjuvant chemotherapy response and prognosis between HR-low/HER2-negative BC and TNBC: an exploratory real-world multicentre cohort study.
Peng J; Hong Y; Chen Q; Xu F; Zhang D; Yao J; Zou Q; Yuan L; Li L; Long Q; Liao L; Liu M; Liu X; Wang S; Yi W
Front Endocrinol (Lausanne); 2024; 15():1347762. PubMed ID: 38567311
[TBL] [Abstract] [Full Text] [Related]
10. Tumor-Infiltrating Lymphocytes in Triple-Negative breast cancer.
Leon-Ferre RA; Jonas SF; Salgado R; Loi S; de Jong V; Carter JM; Nielsen TO; Leung S; Riaz N; Chia S; Jules-Clément G; Curigliano G; Criscitiello C; Cockenpot V; Lambertini M; Suman VJ; Linderholm B; Martens JWM; van Deurzen CHM; Timmermans AM; Shimoi T; Yazaki S; Yoshida M; Kim SB; Lee HJ; Dieci MV; Bataillon G; Vincent-Salomon A; André F; Kok M; Linn SC; Goetz MP; Michiels S;
JAMA; 2024 Apr; 331(13):1135-1144. PubMed ID: 38563834
[TBL] [Abstract] [Full Text] [Related]
11. Gedatolisib in combination with palbociclib and endocrine therapy in women with hormone receptor-positive, HER2-negative advanced breast cancer: results from the dose expansion groups of an open-label, phase 1b study.
Layman RM; Han HS; Rugo HS; Stringer-Reasor EM; Specht JM; Dees EC; Kabos P; Suzuki S; Mutka SC; Sullivan BF; Gorbatchevsky I; Wesolowski R
Lancet Oncol; 2024 Apr; 25(4):474-487. PubMed ID: 38547892
[TBL] [Abstract] [Full Text] [Related]
12. Decision regret of cancer patients after radiotherapy: results from a cross-sectional observational study at a large tertiary cancer center in Germany.
Rühle A; Wieland L; Hinz A; Mehnert-Theuerkauf A; Nicolay NH; Seidel C
J Cancer Res Clin Oncol; 2024 Mar; 150(3):167. PubMed ID: 38546873
[TBL] [Abstract] [Full Text] [Related]
13. The Transcriptome of BT-20 breast cancer Cells Exposed to Curcumin Analog NC2603 Reveals a Relationship between EGR3 Gene Modulation and Cell Migration Inhibition.
Nishimura FG; Sampaio BB; do Couto GO; da Silva AD; da Silva WJ; Peronni KC; Evangelista AF; Hossain M; Dimmock JR; Bandy B; Beleboni RO; Marins M; Fachin AL
Molecules; 2024 Mar; 29(6):. PubMed ID: 38543002
[TBL] [Abstract] [Full Text] [Related]
14. Short-term effectiveness and potential factors of ustekinumab based on real-world data in Chinese psoriasis patients.
Li X; Xie X; Li J; Hu J; Hu K; Tan M; Yang J; Deng S; Liu Y; Zhang M; Kuang Y; Chen J; Liao L; Zhu W
J Dermatolog Treat; 2024 Dec; 35(1):2321188. PubMed ID: 38531383
[TBL] [Abstract] [Full Text] [Related]
15. Intraoperative Evaluation of breast Tissues During breast cancer Operations Using the MasSpec Pen.
Garza KY; King ME; Nagi C; DeHoog RJ; Zhang J; Sans M; Krieger A; Feider CL; Bensussan AV; Keating MF; Lin JQ; Sun MW; Tibshirani R; Pirko C; Brahmbhatt KA; Al-Fartosi AR; Thompson AM; Bonefas E; Suliburk J; Carter SA; Eberlin LS
JAMA Netw Open; 2024 Mar; 7(3):e242684. PubMed ID: 38517441
[TBL] [Abstract] [Full Text] [Related]
16. Does diabetes affect breast cancer survival?
Lawrenson R; Lao C; Stanley J; Teng A; Kuper-Hommel M; Campbell I; Krebs J; Sika-Paotonu D; Koea J; Meredith I; Gurney J
Cancer Rep (Hoboken); 2024 Mar; 7(3):e2040. PubMed ID: 38507264
[TBL] [Abstract] [Full Text] [Related]
17. Omission of adjuvant radiotherapy in low-risk elderly males with breast cancer.
Vo K; Ladbury C; Yoon S; Bazan J; Glaser S; Amini A
Breast Cancer; 2024 May; 31(3):485-495. PubMed ID: 38507145
[TBL] [Abstract] [Full Text] [Related]
18. [Mid-term analysis of prospective cohort study of rivaroxaban in preventing CRT in breast cancer].
Sang D; Fan SM; Li SY; Zhang JT; Wang HM; Zhao XH; Zheng LJ; Liang P; Xi GB; Zhao LM; Zhang YR; Yuan P
Zhonghua Zhong Liu Za Zhi; 2024 Mar; 46(3):256-262. PubMed ID: 38494772
[No Abstract] [Full Text] [Related]
19. [Gemcitabine long-term maintenance chemotherapy benefits patients with survival: a multicenter, real-world study of advanced breast cancer treatment in China].
Yue J; Song GH; Li HP; Sun T; Song LH; Tong ZS; Zhang LL; Song ZC; Ouyang QC; Yang J; Pan YY; Yuan P
Zhonghua Zhong Liu Za Zhi; 2024 Mar; 46(3):249-255. PubMed ID: 38494771
[No Abstract] [Full Text] [Related]
20. Ovarian Suppression: Early Menopause and Late Effects.
Molinelli C; Jacobs F; Nader-Marta G; Borea R; Scavone G; Ottonello S; Fregatti P; Villarreal-Garza C; Bajpai J; Kim HJ; Puglisi S; de Azambuja E; Lambertini M
Curr Treat Options Oncol; 2024 Apr; 25(4):523-542. PubMed ID: 38478329
[TBL] [Abstract] [Full Text] [Related]
[Next]
